Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese PatientsNCT06682572VSTMPhase 2Active not recruiting2025-12Estimated
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationNCT06682806Prelude Therapeutics IncorporatedPhase 2Terminated2026-01-23Actual
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)NCT06685692ALDXPhase 2Completed2025-06-18Actual
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With HypogonadismNCT06689085Halozyme TherapeuticsPhase 3Recruiting2028-03Estimated
Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg UlcersNCT06690177MDWDPhase 2Not yet recruiting2027-12-30Estimated
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsNCT06695845Jazz PharmaceuticalsPhase 2Recruiting2026-12-31Estimated
A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated With the INTERCEPT Blood System for Platelets With LED Illuminator.NCT06697223Cerus CorporationPhase 2Completed2025-06-02Actual
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.NCT06697301Eikon TherapeuticsPhase 2, Phase 3Recruiting2035-12Estimated
CLOVER - CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched RegimenNCT06699836CytoDyn, Inc.Phase 2Active not recruiting2028-01Estimated
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 VariantNCT06701396Vanda PharmaceuticalsPhase 3Recruiting2025-06-30Estimated
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)NCT06708299CRDLPhase 3Recruiting2026-09-21Estimated
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADNCT06709014ANVSPhase 3Active not recruiting2027-12Estimated
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian CancerNCT06710288IBRXPhase 2Recruiting2027-05Estimated
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy InfantsNCT06720038PCVXPhase 2Active not recruiting2027-12Estimated
Efficacy Study of EVO301 in Moderate to Severe Atopic DermatitisNCT06723405EVMNPhase 2Completed2025-11-17Actual
Efficacy and Safety of VDPHL01 in Males With AGANCT06724614MANEPhase 2, Phase 3Active not recruiting2026-02Estimated
A Study of Barzolvolimab in Patients With Atopic DermatitisNCT06727552Celldex TherapeuticsPhase 2Active not recruiting2026-05-06Actual
A Study of Lorigerlimab in Participants With Advanced Solid TumorsNCT06730347MacroGenicsPhase 2Recruiting2027-07Estimated
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria TrialsNCT06736262JSPRPhase 2Terminated2026-07-21Actual
An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyNCT06736509AXSMPhase 3Terminated2025-02-17Actual
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574CytokineticsPhase 3Recruiting2027-09Estimated
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-07-15Actual
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint InNCT06745908IBRXPhase 3Recruiting2028-09Estimated
Avexitide for Treatment of Post-Bariatric HypoglycemiaNCT06747468AMLXPhase 3Active not recruiting2026-07-08Actual
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic FibrosisNCT06747858Arcturus Therapeutics, Inc.Phase 2Recruiting2027-06Estimated
A Study of NE3107 in Early Parkinson'sNCT06757010BIVIPhase 2Completed2026-05-01Actual
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)NCT06757634CELCPhase 3Recruiting2029-03-31Estimated
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)NCT06760546RYTMPhase 3Recruiting2027-03-13Estimated
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514Summit TherapeuticsPhase 3Recruiting2028-04Estimated
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaNCT06767683Alkermes, Inc.Phase 2, Phase 3Recruiting2028-06Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.